Helen M. Bronte-Stewart is a neurologist and an assistant professor of neurology and neurological sciences at Stanford University. [1] She is also the director of the Stanford Movement Disorders Center. [2]
She studied mathematics and physics at the University of York before earning a master's degree in bioengineering from the University of Pennsylvania. She then obtained a medical degree from the Perelman School of Medicine. [3] She was promoted to an associate professorship in December 2006. [4] Bronte-Stewart later held the John E. Cahill Family Professorship, [3] [5] first held by William C. Mobley. Her research focuses on the pathophysiology of Parkinson's Disease and other movement disorders. [3]
Neurology is a branch of medicine dealing with disorders of the nervous system. Neurology deals with the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous systems, including their coverings, blood vessels, and all effector tissue, such as muscle. Neurological practice relies heavily on the field of neuroscience, the scientific study of the nervous system.
Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia, rigidity, and postural instability. These are the four motor symptoms found in Parkinson's disease (PD), after which it is named, dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), and many other conditions. A wide range of causes may lead to this set of symptoms, including neurodegenerative conditions, drugs, toxins, metabolic diseases, and neurological conditions other than PD.
Sidney Gilman is a retired physician, neurologist, and educator. He is an expert on Alzheimer's disease and spent the majority of his career at the University of Michigan, its medical school, and its Health System.
Hypokinesia is one of the classifications of movement disorders, and refers to decreased bodily movement. Hypokinesia is characterized by a partial or complete loss of muscle movement due to a disruption in the basal ganglia. Hypokinesia is a symptom of Parkinson's disease shown as muscle rigidity and an inability to produce movement. It is also associated with mental health disorders and prolonged inactivity due to illness, amongst other diseases.
Enrico Fazzini, D.O., Ph.D. is a neurologist. He is considered an expert on Parkinson's disease and has published numerous research publications on the subject. He has been involved in a number of clinical trials for new pharmaceutical treatments for Parkinson's disease. He attended the University of Osteopathic Medicine and Health Sciences in Des Moines, Iowa. He is board certified in neurology by both the M.D. and D.O. medical boards. He began his practice in 1989. Dr. Enrico Fazzini completed his neurology training at Boston University in 1987 and his fellowship in Movement Disorders at Columbia Presbyterian in 1989. In addition to being a neurologist, Dr. Fazzini has a Ph.D. in Behavioral Neuroscience from Boston University and is an expert on the diagnosis and treatment of patients with traumatic brain injuries.
John Quinn Trojanowski was an American academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.
Anne Buckingham Young is an American physician and neuroscientist who has made major contributions to the study of neurodegenerative diseases, with a focus on movement disorders like Huntington's disease and Parkinson's disease. Young completed her undergraduate studies at Vassar College and earned a dual MD/PhD from Johns Hopkins Medical School. She has held faculty positions at University of Michigan and Harvard University. She became the first female chief of service at Massachusetts General Hospital when she was appointed Chief of Neurology in 1991. She retired from this role and from clinical service in 2012. She is a member of many academic societies and has won numerous awards. Young is also the only person to have been president of both the international Society for Neuroscience and the American Neurological Association.
Andrew John Lees is Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square, London and University College London. In 2011 he was named as the world's most highly cited Parkinson's disease researcher.
Joseph Jankovic is an American neurologist who is a professor in neurology at Baylor College of Medicine in Houston, Texas. He is the Distinguished Chair in Movement Disorders and founder and director of the Parkinson's Disease Center and Movement Disorders Clinic.
David Eidelberg is a Professor of Molecular Medicine at Hofstra Northwell School of Medicine. He is a neuroscientist best known for applying functional imaging of the brain to study neurological diseases.
David Charles is an American neurologist, professor and vice-chair of neurology, and the medical director of Telehealth at Vanderbilt University Medical Center.
Dr. Bhim Sen Singhal is the Director of Neurology at Bombay Hospital Institute of Medical Sciences in Mumbai, India.
Ray Lannom Watts is the seventh president of the University of Alabama at Birmingham (UAB).
Alim Louis Benabid is a French-Algerian emeritus professor, neurosurgeon and member of the French Academy of Sciences, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences.
Mahlon R. DeLong is an American neurologist and professor at the Medical School of Emory University. His research has advanced the understanding and treatment of Parkinson's disease, dystonia, tremor and other neurological movement disorders.
Diane G. Cook is a Parkinson’s disease patient advocate, especially well known for the use of the science of self-efficacy to help newly diagnosed patients with Parkinson’s. She accomplishes this through her roles as a senior patient advocate for the ProjectSpark Foundation. Cook also is a present and past clinical investigator on a number of clinical trials, and a speaker, writer and presenter at numerous local, state, national, and international forums focused on Parkinson’s. She was diagnosed with Parkinson’s disease in 2008.
Michael Jeffrey Aminoff is a clinical neurologist and neurophysiologist whose work currently focuses on treating Parkinson's disease and related movement disorders. He lives in San Francisco, California.
Sue Ellen Leurgans is a biostatistician known for her work on disorders of human movement, including those caused by occupational injury and Parkinson's disease. She is a professor of neurological sciences at the Rush University Medical Center in Chicago.
Erika F. Augustine is an Associate Professor of Neurology and Pediatrics at the University of Rochester Medical Center in Rochester, New York. Augustine co-directs the University of Rochester Batten Center, and is the associate director of both the Center for Health and Technology and the Udall Center of Excellence in Parkinson's Disease Research. Augustine's clinical research and medical practice specialize in pediatric movement disorders. She leads clinical trials for Batten diseases, a group of rare pediatric neurodegenerative disorders, and she has developed a novel telemedicine model to increase the efficacy of remote care for patients with rare diseases.
Jerrold Lee Vitek is an American neurologist. He is the Head of the Neurology Department, Director of the Neuromodulation Research Program, and Center Director of the University of Minnesota Udall Center of Excellence for Parkinson's Research. Vitek's clinical interests include movement disorders and evaluation for deep brain stimulation (DBS) and his current research activities focus on Parkinson's disease, dystonia, tremor and deep brain stimulation.